In Hodgkin lymphoma cells, inhibition of HSP90 led to loss of JAK1, JAK3, and Tyk2, and constitutive pY of STAT1, 3, 5, and 6 was ablated [35]. This evidence concerns the gene JAK1 and Hodgkins lymphoma.